Edward Christopher Dee, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, shared on X:
“Thank you JCO Global Oncology for the invitation to write our paper, led by Emma Zhang, titled ‘From Prediction to Delivery: Reframing Oncology Artificial Intelligence for Global Cancer Care’.
Title: From Prediction to Delivery: Reframing Oncology Artificial Intelligence for Global Cancer Care
Authors: Emma Ruoyi Zhang, James Fan Wu, Milit S Patel, Erin Jay G Feliciano, Nishwant Swami, Nancy Y Lee, Fabio Ynoe Moraes, Edward Christopher Dee
We argue that the promise of AI in global oncology lies not just in better predictions, but in addressing real-world health system challenges: We feature works from ASCO 2026 that demonstrate such advances.
Some of these ASCO 2026 studies examine how AI can support:
- Improving cancer screening and diagnostic pathways
- Extending limited specialist capacity
- Supporting treatment decisions
- Improving access to timely, high-quality care
Importantly, AI cannot substitute for functioning cancer systems.
Local validation, workforce investment, ethical governance, and equitable implementation are essential, particularly in resource-limited settings.
So proud of Emma Zhang, Duke-NUS Medical School, for her leadership and excellent insights, and thank you JCO Global Oncology for the privilege of writing this piece!”
Other articles about artifical intelligence on OncoDaily.